Aileen C Naef1, Marie-Madlen Jeitziner2, Tobias Nef3,4, Matthias Hänggi2, Stephan M Gerber1, Béatrice Jenni-Moser2, René M Müri5, Stephan M Jakob2. 1. Gerontechnology and Rehabilitation Group, University of Bern, Bern, Switzerland. 2. Department of Intensive Care Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. 3. Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. tobias.nef@artorg.unibe.ch. 4. ARTORG Centre for Biomedical Engineering Research, University of Bern, Bern, Switzerland. tobias.nef@artorg.unibe.ch. 5. Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Abstract
BACKGROUND: Delirium has been long considered as a major contributor to cognitive impairments and increased mortality following a critical illness. Pharmacologic and non-pharmacologic strategies are used against delirium in the intensive care unit (ICU), despite these strategies remaining controversial. Previous studies have shown the feasibility of using virtual reality within the ICU setting, and we propose to use this technology to investigate the effect of immersive virtual reality stimulation on the incidence of delirium in the ICU. Moreover, we propose to use motion sensors to determine if patient movement patterns can lead to early prediction of delirium onset. METHODS: This study is conducted as a randomized clinical trial. A total of 920 critically ill patients in the ICU will participate. The control group will receive standard ICU care, whereas the intervention group will, in addition to the standard ICU care, receive relaxing 360-degree immersive virtual reality content played inside a head-mounted display with noise-cancelling headphones, three times a day. The first 100 patients, regardless of their group, will additionally have their movement patterns recorded using wearable and ambient sensors. Follow-up measurements will take place 6 months after discharge from the ICU. DISCUSSION: Delirium is widely present within the ICU setting but lacks validated prevention and treatment strategies. By providing patients with virtual reality stimulation presented inside a head-mounted display and noise-cancelling headphones, participants may be isolated from disturbances on an ICU. It is believed that by doing so, the incidence of delirium will be decrease among these patients. Moreover, identifying movement patterns associated with delirium would allow for early detection and intervention, which may further improve long-term negative outcomes associated with delirium during critical care. TRIAL REGISTRATION: ClinicalTrials.gov NCT04498585 . Registered on August 3, 2020.
RCT Entities:
BACKGROUND:Delirium has been long considered as a major contributor to cognitive impairments and increased mortality following a critical illness. Pharmacologic and non-pharmacologic strategies are used against delirium in the intensive care unit (ICU), despite these strategies remaining controversial. Previous studies have shown the feasibility of using virtual reality within the ICU setting, and we propose to use this technology to investigate the effect of immersive virtual reality stimulation on the incidence of delirium in the ICU. Moreover, we propose to use motion sensors to determine if patient movement patterns can lead to early prediction of delirium onset. METHODS: This study is conducted as a randomized clinical trial. A total of 920 critically illpatients in the ICU will participate. The control group will receive standard ICU care, whereas the intervention group will, in addition to the standard ICU care, receive relaxing 360-degree immersive virtual reality content played inside a head-mounted display with noise-cancelling headphones, three times a day. The first 100 patients, regardless of their group, will additionally have their movement patterns recorded using wearable and ambient sensors. Follow-up measurements will take place 6 months after discharge from the ICU. DISCUSSION: Delirium is widely present within the ICU setting but lacks validated prevention and treatment strategies. By providing patients with virtual reality stimulation presented inside a head-mounted display and noise-cancelling headphones, participants may be isolated from disturbances on an ICU. It is believed that by doing so, the incidence of delirium will be decrease among these patients. Moreover, identifying movement patterns associated with delirium would allow for early detection and intervention, which may further improve long-term negative outcomes associated with delirium during critical care. TRIAL REGISTRATION: ClinicalTrials.gov NCT04498585 . Registered on August 3, 2020.
Authors: Rodrigo B Serafim; Fernando A Bozza; Marcio Soares; Pedro Emanuel A A do Brasil; Bernardo R Tura; E Wesley Ely; Jorge I F Salluh Journal: J Crit Care Date: 2015-04-17 Impact factor: 3.425
Authors: Soenke Boettger; David Garcia Nuñez; Rafael Meyer; Andre Richter; Alain Rudiger; Maria Schubert; Josef Jenewein Journal: Swiss Med Wkly Date: 2018-03-14 Impact factor: 2.193
Authors: Giuseppe Bellelli; Salvatore Speciale; Sara Morghen; Tiziana Torpilliesi; Renato Turco; Marco Trabucchi Journal: J Am Med Dir Assoc Date: 2010-10-02 Impact factor: 4.669
Authors: Mandy Bounds; Stacey Kram; Karen Gabel Speroni; Kim Brice; Mary Anne Luschinski; Stephanie Harte; Marlon G Daniel Journal: Am J Crit Care Date: 2016-11 Impact factor: 2.228
Authors: Margaret A Pisani; So Yeon Joyce Kong; Stanislav V Kasl; Terrence E Murphy; Katy L B Araujo; Peter H Van Ness Journal: Am J Respir Crit Care Med Date: 2009-09-10 Impact factor: 21.405
Authors: E Wesley Ely; Brenda Truman; Ayumi Shintani; Jason W W Thomason; Arthur P Wheeler; Sharon Gordon; Joseph Francis; Theodore Speroff; Shiva Gautam; Richard Margolin; Curtis N Sessler; Robert S Dittus; Gordon R Bernard Journal: JAMA Date: 2003-06-11 Impact factor: 56.272
Authors: An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher Journal: Ann Intern Med Date: 2013-02-05 Impact factor: 25.391
Authors: Stephan M Gerber; Marie-Madlen Jeitziner; Samuel E J Knobel; Urs P Mosimann; René M Müri; Stephan M Jakob; Tobias Nef Journal: Front Med (Lausanne) Date: 2019-12-10